Client Stories

bitbio herobit.bio logo

Bit.bio is a leading biotech firm producing artificial human cells for drug discovery and research. This pioneering company is dedicated to advancing medical research through innovative cell technologies. They aspire to be the world’s leading synthetic biology company that provides human cells for research, drug discovery, and cell therapy. They are driven by a bold vision: empowering biomedical innovation and a new generation of cures through precision-programed human cells.bit.bio approached Freeman Clarke with a number of issues concerning security, compliance, and IPO readiness.

Challenges

Bit.bio faced multiple challenges related to their IT readiness and compliance:

Collectively, these challenges were preventing the business from innovating quickly, leveraging the huge volume of data being generated, and having confidence to move to the next level of global regulatory compliance.

Solutions Provided

To address these challenges, Freeman Clarke implemented a multifaceted approach:

1. Gap Analysis and Discovery Phase

2. Board Executive Alignment

3. IT Security Assessment

4. Vendor Management and Policy Updates

5. Recruitment Support

Outcomes and Benefits

The solutions provided led to significant improvements for the client:

ISO 27001 Audit Readiness

Data Strategy Implementation

IT Recruitment and Planning

Conclusion

Through targeted interventions and strategic guidance, Freeman Clarke has helped bit.bio significantly enhance its IT readiness, compliance, and data strategy. These improvements have positioned them for continued innovation and growth in the biotech sector, ensuring robust cyber security and compliance as they prepare for public market readiness.

“We are very pleased with the Principal’s work to date. He is extremely professional, knowledgeable, and thoughtful as he interacts with all levels of the company to best understand the gaps and opportunities to define our IT roadmap. He is very effective, and I appreciate his expertise.”

Subscribe to our Business Insights

Plain English board-level briefings focused on technology strategies to deliver competitive advantage and business success.

* Please enter an email address
newnewsletterrecipient

You can unsubscribe at any time.

Thank you.

You’ll now receive regular expert business insights.

Call us on 0203 020 1864 with any questions.

Graeme Freeman
Co-Founder and Director

Subscribe to our Business Insights

Plain English board-level briefings focused on technology strategies to deliver competitive advantage and business success.

* Please enter an email address
newnewsletterrecipient

You can unsubscribe at any time.

Thank you.

You’ll now receive regular expert business insights.

Call us on 0203 020 1864 with any questions.

Popular content for CEOs

Latest briefings written by IT experts
I would like to receive:

Popular content for CEOs

Latest briefings written by IT experts
I would like to receive: